LY2495655 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Muscle Weakness
Conditions
Muscle Weakness
Trial Timeline
May 1, 2012 → Dec 1, 2013
NCT ID
NCT01604408About LY2495655 + Placebo
LY2495655 + Placebo is a phase 2 stage product being developed by Eli Lilly for Muscle Weakness. The current trial status is completed. This product is registered under clinical trial identifier NCT01604408. Target conditions include Muscle Weakness.
What happened to similar drugs?
2 of 20 similar drugs in Muscle Weakness were approved
Approved (2) Terminated (0) Active (18)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01604408 | Phase 2 | Completed |
| NCT01369511 | Phase 2 | Completed |
| NCT01341470 | Phase 1 | Completed |
Competing Products
20 competing products in Muscle Weakness